These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9642325

  • 1. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z, Zhang J, Zhang S, Li L.
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [Abstract] [Full Text] [Related]

  • 2. [Urine levels of soluble interleukin 2 receptor and free light chain immunoglobulins in lupus nephritis].
    Ling SH.
    Zhonghua Yi Xue Za Zhi; 1993 Dec; 73(12):756-8, 774. PubMed ID: 8143195
    [Abstract] [Full Text] [Related]

  • 3. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 4. [The use of measuring serum soluble IL-2 receptor levels in cyclosporine-A treated lupus nephritis].
    Zheng X, Lin M, Cui X, Yao Q, Zhou G, Guo Z.
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep 02; 26(3):338-41. PubMed ID: 8586406
    [Abstract] [Full Text] [Related]

  • 5. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D.
    Roum Arch Microbiol Immunol; 2001 Sep 02; 60(3):183-201. PubMed ID: 12165973
    [Abstract] [Full Text] [Related]

  • 6. Soluble interleukin-2 receptor levels in lupus nephritis.
    Laut J, Senitzer D, Petrucci R, Sablay LB, Barland P, Glicklich D.
    Clin Nephrol; 1992 Oct 02; 38(4):179-84. PubMed ID: 1424303
    [Abstract] [Full Text] [Related]

  • 7. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
    Horák P, Hermanová Z, Ordeltová M, Faltýnek L, Kusá L, Budíková M, Vavrdová V, Opíchalová D, Ciferská H, Scudla V.
    Vnitr Lek; 2004 Jun 02; 50(6):422-7. PubMed ID: 15346634
    [Abstract] [Full Text] [Related]

  • 8. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.
    Srp Arh Celok Lek; 2002 Aug 02; 130 Suppl 3():38-41. PubMed ID: 12583312
    [Abstract] [Full Text] [Related]

  • 9. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 02; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 10. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ.
    Saudi Med J; 2005 Jul 02; 26(7):1085-91. PubMed ID: 16047057
    [Abstract] [Full Text] [Related]

  • 11. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec 02; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 12. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
    Schroeder TJ, Helling T, McKenna RM, Rush D, Jeffrey JR, Brewer B, Martin LA, Traylor D, Fisher RA, First MR.
    Transplantation; 1992 Jan 02; 53(1):34-40. PubMed ID: 1733082
    [Abstract] [Full Text] [Related]

  • 13. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 14. IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients.
    Dong G, Ye R, Shi W, Liu S, Wang T, Yang X, Yang N, Yu X.
    Chin Med J (Engl); 2003 Apr 13; 116(4):543-8. PubMed ID: 12875719
    [Abstract] [Full Text] [Related]

  • 15. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, Simon LS.
    J Rheumatol; 1996 Apr 13; 23(4):654-8. PubMed ID: 8730122
    [Abstract] [Full Text] [Related]

  • 16. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT, Chen YM, Lan JL, Chen HH, Chen YH, Chen DY, Hsieh CW, Wen MC.
    Lupus; 2011 Nov 13; 20(13):1404-10. PubMed ID: 21946514
    [Abstract] [Full Text] [Related]

  • 17. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D, Direskeneli H, Khamashta M, Hughes GR.
    J Rheumatol; 1999 Jan 13; 26(1):103-9. PubMed ID: 9918249
    [Abstract] [Full Text] [Related]

  • 18. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
    Xu J, Wang B.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb 13; 19(2):82-4. PubMed ID: 10921108
    [Abstract] [Full Text] [Related]

  • 19. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD, Engel EE, Charley MR, Medsger TA.
    J Rheumatol; 1996 Apr 13; 23(4):646-9. PubMed ID: 8730120
    [Abstract] [Full Text] [Related]

  • 20. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD, Rossi TM, Lebenthal E.
    Res Commun Mol Pathol Pharmacol; 1995 Jan 13; 87(1):21-6. PubMed ID: 7735726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.